Submitted by Anonymous (not verified) on 17 October 2025 - 11:30
Opinion/decision on a Paediatric investigation plan (PIP): Sotyktu, Deucravacitinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Musculoskeletal and connective tissue disorders, PIP number: P/0319/2024
Source: